Cocaine use disorder patients develop distinct patterns of regulation of acth secretion by a vasopressin agonist and oxytocin: Report on a laboratory study

Background: : Oxytocin and Vasopressin systems in the brain sustain adaptation to stressors. Cocaine being a stressor, it may alter brain homeostatic function. This dysregulation may entrench cocaine use disorder. Method: : This is a human laboratory study of the effects of intranasal desmopressin (...

Full description

Bibliographic Details
Main Authors: Wilfrid Noël Raby, Matthew Heller, Demetrios Milliaressis, C. Jean Choi, Cale Basaraba, Frances R. Levin, Sarah Church, Martina Pavlicova, Edward V. Nunes
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Drug and Alcohol Dependence Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772724623000288
_version_ 1797801645446266880
author Wilfrid Noël Raby
Matthew Heller
Demetrios Milliaressis
C. Jean Choi
Cale Basaraba
Frances R. Levin
Sarah Church
Martina Pavlicova
Edward V. Nunes
author_facet Wilfrid Noël Raby
Matthew Heller
Demetrios Milliaressis
C. Jean Choi
Cale Basaraba
Frances R. Levin
Sarah Church
Martina Pavlicova
Edward V. Nunes
author_sort Wilfrid Noël Raby
collection DOAJ
description Background: : Oxytocin and Vasopressin systems in the brain sustain adaptation to stressors. Cocaine being a stressor, it may alter brain homeostatic function. This dysregulation may entrench cocaine use disorder. Method: : This is a human laboratory study of the effects of intranasal desmopressin (a Vasopressin 1b receptor agonist) and oxytocin on ACTH secretion in cocaine use disorder patients versus a control group. It consisted of two endocrine challenges performed on consecutive days. On day 1, the effect of intranasal desmopressin (80 IU) on ACTH secretion was measured. On day 2, a pre-treatment with intranasal oxytocin (24 IU) preceded intranasal desmopressin to monitor its effect on desmopressin-induced ACTH secretion. We hypothesized that the effect of intranasal oxytocin in controls would differ from the effect in cocaine use disorder patients. Results: : Forty-three patients were included in this study: 14 controls and 29 cocaine use disorder patients. Significant differences were noted in the direction of change of ACTH secretion between the two groups. In cocaine use disorder patients, overall ACTH secretion was on average 2.7 pg/ml/min higher after intranasal desmopressin than after intranasal oxytocin/desmopressin (t292 = 2.91, p = 0.004). The opposite was observed in controls: overall ACTH secretion averaged 3.3 pg/ml/min less after intranasal desmopressin than after intranasal oxytocin/desmopressin (t292 = -2.35, p = 0.02). Conclusion: : Intranasal oxytocin and desmopressin revealed a pattern of ACTH secretion in cocaine use disorder patients that is distinct from a non-addicted control group. (ClinicalTrial.gov00255357, 10/2014)
first_indexed 2024-03-13T04:53:37Z
format Article
id doaj.art-804d3b4dcb8546618b587daece9f1593
institution Directory Open Access Journal
issn 2772-7246
language English
last_indexed 2024-03-13T04:53:37Z
publishDate 2023-06-01
publisher Elsevier
record_format Article
series Drug and Alcohol Dependence Reports
spelling doaj.art-804d3b4dcb8546618b587daece9f15932023-06-18T05:04:21ZengElsevierDrug and Alcohol Dependence Reports2772-72462023-06-017100158Cocaine use disorder patients develop distinct patterns of regulation of acth secretion by a vasopressin agonist and oxytocin: Report on a laboratory studyWilfrid Noël Raby0Matthew Heller1Demetrios Milliaressis2C. Jean Choi3Cale Basaraba4Frances R. Levin5Sarah Church6Martina Pavlicova7Edward V. Nunes8Division on Substance Abuse, Department of Psychiatry, Montefiore Medical Center, Albert Einstein College of Medicine, 1510 Waters Place, 2nd Floor, Bronx, NY, 10461; Division on Substance Use Disorders, Department of Psychiatry, Columbia University Irving Medical Center and the New York State Psychiatric Institute, New York, NY, USA; Corresponding author.Division on Substance Use Disorders, Department of Psychiatry, Columbia University Irving Medical Center and the New York State Psychiatric Institute, New York, NY, USADivision on Substance Use Disorders, Department of Psychiatry, Columbia University Irving Medical Center and the New York State Psychiatric Institute, New York, NY, USADivision of Mental Health Data Science, New York State Psychiatric Institute, New York, NY, USADivision of Mental Health Data Science, New York State Psychiatric Institute, New York, NY, USADivision on Substance Use Disorders, Department of Psychiatry, Columbia University Irving Medical Center and the New York State Psychiatric Institute, New York, NY, USAWholeview Wellness Centers, 369 Lexington Avenue, Suite 14A, New York City, NY, 10017, USADepartment of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, USADivision on Substance Use Disorders, Department of Psychiatry, Columbia University Irving Medical Center and the New York State Psychiatric Institute, New York, NY, USABackground: : Oxytocin and Vasopressin systems in the brain sustain adaptation to stressors. Cocaine being a stressor, it may alter brain homeostatic function. This dysregulation may entrench cocaine use disorder. Method: : This is a human laboratory study of the effects of intranasal desmopressin (a Vasopressin 1b receptor agonist) and oxytocin on ACTH secretion in cocaine use disorder patients versus a control group. It consisted of two endocrine challenges performed on consecutive days. On day 1, the effect of intranasal desmopressin (80 IU) on ACTH secretion was measured. On day 2, a pre-treatment with intranasal oxytocin (24 IU) preceded intranasal desmopressin to monitor its effect on desmopressin-induced ACTH secretion. We hypothesized that the effect of intranasal oxytocin in controls would differ from the effect in cocaine use disorder patients. Results: : Forty-three patients were included in this study: 14 controls and 29 cocaine use disorder patients. Significant differences were noted in the direction of change of ACTH secretion between the two groups. In cocaine use disorder patients, overall ACTH secretion was on average 2.7 pg/ml/min higher after intranasal desmopressin than after intranasal oxytocin/desmopressin (t292 = 2.91, p = 0.004). The opposite was observed in controls: overall ACTH secretion averaged 3.3 pg/ml/min less after intranasal desmopressin than after intranasal oxytocin/desmopressin (t292 = -2.35, p = 0.02). Conclusion: : Intranasal oxytocin and desmopressin revealed a pattern of ACTH secretion in cocaine use disorder patients that is distinct from a non-addicted control group. (ClinicalTrial.gov00255357, 10/2014)http://www.sciencedirect.com/science/article/pii/S2772724623000288IntranasalOxytocinCocaineStressACTH
spellingShingle Wilfrid Noël Raby
Matthew Heller
Demetrios Milliaressis
C. Jean Choi
Cale Basaraba
Frances R. Levin
Sarah Church
Martina Pavlicova
Edward V. Nunes
Cocaine use disorder patients develop distinct patterns of regulation of acth secretion by a vasopressin agonist and oxytocin: Report on a laboratory study
Drug and Alcohol Dependence Reports
Intranasal
Oxytocin
Cocaine
Stress
ACTH
title Cocaine use disorder patients develop distinct patterns of regulation of acth secretion by a vasopressin agonist and oxytocin: Report on a laboratory study
title_full Cocaine use disorder patients develop distinct patterns of regulation of acth secretion by a vasopressin agonist and oxytocin: Report on a laboratory study
title_fullStr Cocaine use disorder patients develop distinct patterns of regulation of acth secretion by a vasopressin agonist and oxytocin: Report on a laboratory study
title_full_unstemmed Cocaine use disorder patients develop distinct patterns of regulation of acth secretion by a vasopressin agonist and oxytocin: Report on a laboratory study
title_short Cocaine use disorder patients develop distinct patterns of regulation of acth secretion by a vasopressin agonist and oxytocin: Report on a laboratory study
title_sort cocaine use disorder patients develop distinct patterns of regulation of acth secretion by a vasopressin agonist and oxytocin report on a laboratory study
topic Intranasal
Oxytocin
Cocaine
Stress
ACTH
url http://www.sciencedirect.com/science/article/pii/S2772724623000288
work_keys_str_mv AT wilfridnoelraby cocaineusedisorderpatientsdevelopdistinctpatternsofregulationofacthsecretionbyavasopressinagonistandoxytocinreportonalaboratorystudy
AT matthewheller cocaineusedisorderpatientsdevelopdistinctpatternsofregulationofacthsecretionbyavasopressinagonistandoxytocinreportonalaboratorystudy
AT demetriosmilliaressis cocaineusedisorderpatientsdevelopdistinctpatternsofregulationofacthsecretionbyavasopressinagonistandoxytocinreportonalaboratorystudy
AT cjeanchoi cocaineusedisorderpatientsdevelopdistinctpatternsofregulationofacthsecretionbyavasopressinagonistandoxytocinreportonalaboratorystudy
AT calebasaraba cocaineusedisorderpatientsdevelopdistinctpatternsofregulationofacthsecretionbyavasopressinagonistandoxytocinreportonalaboratorystudy
AT francesrlevin cocaineusedisorderpatientsdevelopdistinctpatternsofregulationofacthsecretionbyavasopressinagonistandoxytocinreportonalaboratorystudy
AT sarahchurch cocaineusedisorderpatientsdevelopdistinctpatternsofregulationofacthsecretionbyavasopressinagonistandoxytocinreportonalaboratorystudy
AT martinapavlicova cocaineusedisorderpatientsdevelopdistinctpatternsofregulationofacthsecretionbyavasopressinagonistandoxytocinreportonalaboratorystudy
AT edwardvnunes cocaineusedisorderpatientsdevelopdistinctpatternsofregulationofacthsecretionbyavasopressinagonistandoxytocinreportonalaboratorystudy